Clinical Trial Detail

NCT ID NCT02357810
Title Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Northwestern University
Indications

sarcoma

osteosarcoma

liposarcoma

Therapies

Topotecan + Pazopanib

Age Groups: adult

No variant requirements are available.